August 24, 2020
3,656
57
28
2.32%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
22:45Now PlayingThe U.S. Food and Drug Administration confirmed that an Emergency Use Authorization was granted for the use of Covid-19 convalescent plasma for the treatment of hospitalized patients, before an expected announcement by President Donald Trump.
Covid-19 convalescent plasma is collected from individuals whose plasma contains anti-SARS-CoV-2 antibodies.
The EUA was granted based on a review of historical evidence using convalescent plasma in prior outbreaks of respiratory viruses, certain preclinical evidence, results from small clinical trials conducted during the current outbreak and data from the ongoing National Convalescent Plasma Expanded Access Protocol, according to a letter posted on the FDA website.
Adequate and well-controlled randomized trials remain necessary for a definitive demonstration of efficacy and to determine the appropriate patient populations and optimal product attributes.
Trump is expected to announce the emergency authorization at a press conference later Sunday.
Subscribe to our YouTube channel
QUICKTAKE ON SOCIAL:
Follow QuickTake on Twitter: twitter.com/quicktake
Like QuickTake on Facebook: facebook.com/quicktake
Follow QuickTake on Instagram: instagram.com/quicktake
Subscribe to our newsletter
Email us at quicktakenews@gmail.com
QuickTake by Bloomberg is a global news network delivering up-to-the-minute analysis on the biggest news, trends and ideas for a new generation of leaders.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.